These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2837265)

  • 21. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
    Pletnev AG
    Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Persistence of the tick-borne encephalitis and Langat viruses in mouse thymocytes in experimental infection against a background of cyclophosphane-induced immunodepression].
    Vargin VV; Semenov BF
    Vopr Virusol; 1985; 30(5):577-81. PubMed ID: 3000083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mosquito-borne viruses in western Europe: a review.
    Lundström JO
    J Vector Ecol; 1999 Jun; 24(1):1-39. PubMed ID: 10436876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine enhances virally induced T-cell-mediated demyelination. The effect of cyclosporine on a demyelinating virus infection.
    Fazakerley JK; Webb HE
    J Neurol Sci; 1987 Mar; 78(1):35-50. PubMed ID: 3033157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus.
    Colombage G; Hall R; Pavy M; Lobigs M
    Virology; 1998 Oct; 250(1):151-63. PubMed ID: 9770429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice.
    Crouch CF; Mackenzie A; Dimmock NJ
    J Infect Dis; 1982 Sep; 146(3):411-6. PubMed ID: 6286798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The possibility of preparing a live vaccine against tick-borne encephalitis from Malay langat virus TP-21].
    Il'enko VI; Platonov VG; Prozorova IN; Smorodintsev AA
    Tr Inst Im Pastera; 1989; 65():126-32. PubMed ID: 2560847
    [No Abstract]   [Full Text] [Related]  

  • 29. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.
    Barrett AD; Guest AR; Mackenzie A; Dimmock NJ
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cycloleucine on SFV A7(74) infection in mice.
    Amor S; Webb HE
    Br J Exp Pathol; 1987 Apr; 68(2):225-35. PubMed ID: 3034321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of langat virus infection by lead intoxication--influence on host defenses.
    Thind IS; Singh NP
    Acta Virol; 1977 Jul; 21(4):317-25. PubMed ID: 20766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections.
    Vargin VV; Semenov BF
    Acta Virol; 1986 Jul; 30(4):303-8. PubMed ID: 2876611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of defective interfering virus in the brains of mice by an avirulent, in contrast with a virulent, strain of Semliki forest virus.
    Woodward CG; Smith H
    Br J Exp Pathol; 1975 Aug; 56(4):363-72. PubMed ID: 1174462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A live vaccine against tick-borne encephalitis: integrated studies. I. Basic properties and behaviour of the E5 "14" Clone (Langat virus).
    Mayer V
    Acta Virol; 1975 May; 19(3):209-18. PubMed ID: 239576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin synthesis in nude (nu/nu), nu/+ and reconstituted nu/nu mice infected with a demyelinating strain of Semliki Forest virus.
    Suckling AJ; Jagelman S; Webb HE
    Clin Exp Immunol; 1982 Feb; 47(2):283-8. PubMed ID: 6280913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of Semliki Forest virus encephalitis.
    Fazakerley JK
    J Neurovirol; 2002 Dec; 8 Suppl 2():66-74. PubMed ID: 12491154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
    Dimmock NJ; Kennedy SI
    J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of the Tahyña virus on Langat virus persistence in the central nervous system of the mouse].
    Semenov BF; Vargin VV; Ozherelkov SV
    Vopr Virusol; 1981; (6):724-8. PubMed ID: 6278778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological relationship between a demyelinating RNA enveloped budding virus (Semliki Forest) and brain glycolipids.
    Khalili-Shirazi A; Gregson N; Webb HE
    J Neurol Sci; 1986 Nov; 76(1):91-103. PubMed ID: 3783190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of immunoglobulin-containing cells in the central nervous system of the mouse following infection with the demyelinating strain of Semliki Forest virus.
    Parsons LM; Webb HE
    Br J Exp Pathol; 1989 Jun; 70(3):247-55. PubMed ID: 2548561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.